Dr. Reddy's Launches Cash Offer for OctoPlus for EUR 0.52/Share
Dr. Reddy's Laboratories Limited (NYSE: RDY) [“Dr. Reddy's”], together
with its subsidiaries, launches the recommended public offer to acquire
all the issued and outstanding shares of OctoPlus N.V. (Euronext
Amsterdam: OCTO), a service-based specialty pharmaceutical company, at
an offer price of EUR 0.52 (cum dividend) per share. The Offer Period
commences at 14 December 2012 at 09:00 CET and ends on 8 February 2013
at 18:00 CET, unless extended.
Shareholders (including certain members of the Boards) holding in
aggregate 63.5% of the issued and outstanding ordinary shares of
OctoPlus have entered into irrevocable undertakings to tender their
shares under the Offer.